Tamoxifen as an Alternative to Surgical Resection for Selected Geriatric Patients With Primary Breast Cancer
- 1 May 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 124 (5) , 548-551
- https://doi.org/10.1001/archsurg.1989.01410050038006
Abstract
• Thirty elderly patients with primary operable breast cancer were treated initially, because of refusal of surgery or because of infirmity, only with the antiestrogen tamoxifen citrate. Nineteen patients had regression of the primary tumor (complete in five and partial in 14). Eight patients were stable with no change, and three had measurable increases in the size of their primary tumors. Nine of the 30 eventually required locoregional treatment with surgery or radiotherapy for progression or recrudescence of their tumors after initial regression. No patient developed uncontrollable locoregional disease. For selected geriatric patients, treatment with tamoxifen alone permits a delay of surgery, which for some exceeds life expectancy. (Arch Surg. 1989;124:548-551)Keywords
This publication has 4 references indexed in Scilit:
- BREAST CANCER AND AGING: Clinical InteractionsHematology/Oncology Clinics of North America, 2000
- The Effects of Regulation, Competition, and Ownership on Mortality Rates among Hospital InpatientsNew England Journal of Medicine, 1988
- Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984